Therapeutic Peptides Expanded 2 intermediate
Zagotenemab: Oligopeptide Research Reference
Zagotenemab, a bioactive peptide compound with documented applications in biomedical research, pharmacological studies, and therapeutic development
By Encyclopeptide Editorial | 1 min read
therapeutic-peptides-expanded-2 peptide oligopeptide
Overview
Zagotenemab is a bioactive peptide with well-characterized properties and therapeutic applications.
Structure
| Property | Value |
|---|---|
| Name | Zagotenemab |
| Sequence | Humanized IgG4 monoclonal antibody targeting conformational tau epitope |
| Length | ~1325 amino acids |
| Molecular Weight | ~147 kDa |
| Category | Count |
Mechanism of Action
Selectively binds a conformational epitope of soluble tau aggregates (not monomeric or fibrillar tau), promoting clearance of toxic tau oligomers via microglial phagocytosis
References
- Wikipept Peptide Database
- Primary literature (see individual entries)
Test Your Knowledge
Reinforce what you learned about Zagotenemab: Oligopeptide Research Reference with interactive quizzes on Wikipept.
Take a Quiz on Wikipept